Jiangxi Rimag Group Finalizes First Data Trading Batch, Enhancing Medical Imaging Market Presence

Reuters
Sep 02
Jiangxi Rimag Group Finalizes First Data Trading Batch, Enhancing Medical Imaging Market Presence

Jiangxi Rimag Group Co., Ltd. has completed its first batch of data trading through a collaboration with a data technology company and Beijing International Data Exchange Co., Ltd. This milestone was achieved under the Tripartite Cooperation Contract for Data Trading, finalized on September 1, 2025. The trading initiative, conducted on the BIDE platform, is intended to standardize the integration and market-based trading of data elements. This collaboration not only introduces a new monetization model for Jiangxi Rimag's core data assets but also underscores the company's expertise and market value in the medical imaging data sector. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Rimag Group Co. Ltd. published the original content used to generate this news brief on September 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10